Publication date: Available online 3 December 2018
Source: Journal of the American Academy of Dermatology
Author(s): Eden Lake
https://ift.tt/2Rvumdp
Publication date: Available online 3 December 2018
Source: Journal of the American Academy of Dermatology
Author(s): Eden Lake
Publication date: Available online 3 December 2018
Source: Journal of the American Academy of Dermatology
Author(s): Eden Lake
Publication date: Available online 3 December 2018
Source: Journal of the American Academy of Dermatology
Author(s): Eden Lake
Publication date: Available online 3 December 2018
Source: Journal of the American Academy of Dermatology
Author(s): Eden Lake
Publication date: Available online 3 December 2018
Source: Journal of the American Academy of Dermatology
Author(s): Eden Lake
The previous studies suggested an association between osteoporosis and sudden sensory neural hearing loss (SSNHL). The aim of the present study was to evaluate the association between osteoporosis and benign paroxysmal positional vertigo (BPPV).
Data from the Korean National Health Insurance Service-National Sample Cohort of participants who were ≥ 50 years old were collected from 2002 to 2013. A total of 13,484 BPPV participants were matched with respect to age group, sex, income group, region of residence, hypertension, diabetes, and dyslipidemia to 53,936 controls. In both the BPPV and control groups, the previous histories of osteoporosis were evaluated. Crude (simple) and adjusted odds ratios (ORs) of osteoporosis for BPPV were analyzed using unconditional logistic regression analyses. Subgroup analyses were conducted according to age, sex, and BPPV frequency.
A total of 18.64% (2514/13,464) of the BPPV group and 12.21% (6589/53,936) of the control group had a history of osteoporosis (P < 0.001). The adjusted OR of osteoporosis for BPPV was 1.29 (95% CI = 1.23–1.35, P < 0.001). In the subgroup analysis according to age and sex, the ≥ 70-year-old men did not demonstrate a high adjusted OR of osteoporosis for BPPV. All other age and sex subgroups demonstrated high adjusted ORs of osteoporosis for BPPV.
Osteoporosis increased the risk of BPPV in the population aged ≥ 50 years. The OR of osteoporosis was higher in the frequent BPPV group than in the less frequent BPPV group.
The present work focused on the effects of different reagents on the remediation of arsenic and chromium co-contaminated soil by electrokinetic technology coupled with permeable reactive barrier (EK-PRB). In a running of EK-PRB, reductant (ascorbic acid, sodium citrate) and chelating agent (EDTA-2Na) were used to pretreat contaminated soil together with CaAl-LDH as reactive materials for PRB. As a result, the chelating agent improved the removals of As and Cr in co-contaminated soil. However, the reducing agent only increased As removal. When 0.05 M sodium citrate was used in pretreatment, the As removal attained the maximum of 50.5%, although Cr removal was only 44.1% at the same time. When the contaminated soil was pretreated with 0.01 M EDTA-2Na, the Cr removal increased to 54.28%, although As removal was only 26.3%. After EK-PRB, the As and Cr were efficiently captured by CaAl-LDH, resulting in maximal fixed amounts of 126.5 mg/kg (As) and 1507.6 mg/kg (Cr). The XRD and FITR analyses of LDH indicated that As was mainly adsorbed on the surface of LDH. As for Cr, it was mainly intercalated into interlayer of LDH.